Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?

Author: Mueller Lisa L   Taketsuma Costa Silvia Moreira  

Publisher: Informa Healthcare

ISSN: 1354-3776

Source: Expert Opinion on Therapeutic Patents, Vol.24, Iss.1, 2014-01, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract